IRISanRaf

GUADAGNI, FIORELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.054
AS - Asia 4.456
EU - Europa 610
Continente sconosciuto - Info sul continente non disponibili 179
SA - Sud America 60
AF - Africa 36
OC - Oceania 14
Totale 11.409
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.077
TR - Turchia 2.388
CN - Cina 1.065
CA - Canada 969
SG - Singapore 881
IT - Italia 254
EU - Europa 177
IE - Irlanda 98
DE - Germania 59
BR - Brasile 50
IN - India 49
FI - Finlandia 33
RU - Federazione Russa 29
SC - Seychelles 29
HK - Hong Kong 24
FR - Francia 20
GB - Regno Unito 18
RO - Romania 16
UA - Ucraina 14
ID - Indonesia 13
NL - Olanda 13
AU - Australia 12
ES - Italia 8
MX - Messico 7
SE - Svezia 7
CL - Cile 6
JP - Giappone 6
DK - Danimarca 5
LT - Lituania 5
PK - Pakistan 5
GR - Grecia 4
PH - Filippine 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
KR - Corea 3
PL - Polonia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CH - Svizzera 2
HU - Ungheria 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CR - Costa Rica 1
EC - Ecuador 1
EG - Egitto 1
GH - Ghana 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
NE - Niger 1
PY - Paraguay 1
SI - Slovenia 1
Totale 11.409
Salva come PNG Salva come JPEG
Città #
Kocaeli 2.103
San Mateo 1.619
Toronto 958
Wilmington 464
Houston 423
Santa Clara 343
Lawrence 322
Princeton 322
Beijing 287
Singapore 258
Chandler 210
Fairfield 129
Ashburn 124
Seattle 124
Woodbridge 101
Shanghai 99
Guangzhou 66
Los Angeles 56
Cambridge 55
Rome 43
Dublin 35
Shenzhen 32
Helsinki 31
Redwood City 31
Hong Kong 19
Saint Petersburg 17
Wuhan 16
Quanzhou 15
Redmond 15
Brooklyn 14
Milan 14
Jiaxing 13
Rui'an 12
Xi'an 12
Nanjing 11
Wuxi 11
Council Bluffs 9
Kyiv 9
Pesaro 9
Pune 9
Bandung 8
Bari 8
Dongyang 8
Jinhua 8
Taizhou 8
Nantong 7
The Dalles 7
Vicenza 7
Xuzhou 7
Zhengzhou 7
Changsha 6
Hefei 6
Munich 6
Philadelphia 6
Rockville 6
Washington 6
Jinan 5
Qingdao 5
Aarhus 4
Brescia 4
Hangzhou 4
Phoenix 4
Shijiazhuang 4
São Paulo 4
West Jordan 4
Zibo 4
Austin 3
Belo Horizonte 3
Boardman 3
Borgosesia 3
Darwin 3
Fiesole 3
Foshan 3
Frankfurt am Main 3
Groningen 3
Grugliasco 3
Jakarta 3
Jining 3
Kaunas 3
Las Pinas 3
Leawood 3
Madrid 3
Mexico City 3
Naples 3
New Jersey 3
New York 3
Norwalk 3
Pataskala 3
Sanming 3
Shenyang 3
Woking 3
Yiwu 3
Zhuhai 3
Zhuji 3
Amsterdam 2
Andover 2
Athens 2
Auckland 2
Bergamo 2
Borås 2
Totale 8.689
Salva come PNG Salva come JPEG
Nome #
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 109
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 100
A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience 72
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 70
TAG-72 (CA 72-4 ASSAY) AS A COMPLEMENTARY SERUM TUMOR-ANTIGEN TO CARCINOEMBRYONIC ANTIGEN IN MONITORING PATIENTS WITH COLORECTAL-CANCER 70
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments 70
CARCINOEMBRYONIC ANTIGEN REGULATION IN HUMAN COLORECTAL TUMOR-CELLS BY A SITE-SELECTIVE CYCLIC-AMP ANALOG - A COMPARISON WITH INTERFERON-GAMMA 65
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 62
BIOLOGIC EVALUATION OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 AND CARCINOEMBRYONIC ANTIGEN EXPRESSION IN COLORECTAL-CANCER .1 59
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 57
A Novel K-ras Mutation in Colorectal Cancer. A Case Report and Literature Review 56
Correlation between soluble CD40 ligand, VEGF plasma levels and haemostatic activation in non-small cell lung cancer (NSCLC) 54
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 53
In vitro interactions between blood platelets and human colorectal tumor cells 52
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 51
Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 51
“Personal and sensitive data in the e-health-IoT universe” 51
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')(2) (F023C5) in CEA serum-negative colorectal cancer patients 50
Association between carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content of colorectal cancer 50
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers 50
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 50
Activation of blood coagulation in breast cancer - relationship to clinical outcome 50
MUTATIONAL ANALYSIS IN INHERITED BREAST/OVARIAN CANCER PATIENTS FROM CENTRAL ITALY REGINA ELENA CANCER INSTITUTE OF ROME, ITALY 50
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 49
Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells 49
Role of interleukin-6 in the diagnosis of acute aortic dissection 49
Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo 48
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 48
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 48
Metabolic Syndrome (MetS) in Metastatic (m) Colorectal Cancer (CRC) Patients (pts) Might Delay the Onset of Cachexia 47
TARGETING ANTIBODIES TO LIVE TUMOR-TISSUE IN 3-D HISTOCULTURE 47
SERUM LEPTIN LEVELS IN COLORECTAL CANCER PATIENTS 47
BIOLOGIC AND CLINICAL CORRELATIONS AMONG PLOIDY, CELL-KINETICS, AND THE TUMOR-ASSOCIATED GLYCOPROTEIN-72 TISSUE EXPRESSION IN COLORECTAL-CANCER - PRELIMINARY FINDINGS 47
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation 47
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 47
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 47
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 47
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 46
EVALUATION OF TAG-72 (CA-72-4) SERUM MARKER IN PRIMARY DIAGNOSIS IN OVARIAN-CANCER - A COMPARISON WITH CA-125 46
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 46
TUMOR-ASSOCIATED GLYCOPROTEIN-72 SERUM LEVELS COMPLEMENT CARCINOEMBRYONIC ANTIGEN LEVELS IN MONITORING PATIENTS WITH GASTROINTESTINAL CARCINOMA - A LONGITUDINAL-STUDY 46
BRCA1 and BRCA2 mutational analysis in inherited breast/ovarian cancer patients from central Italy 45
Evaluation of the clinical impact of serum tumor markers in gastric cancer. A prospective longitudinal study 45
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 45
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 45
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 45
A METASTATIC NUDE-MOUSE MODEL OF HUMAN PANCREATIC-CANCER CONSTRUCTED ORTHOTOPICALLY WITH HISTOLOGICALLY INTACT PATIENT SPECIMENS 45
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 45
Biological response modifiers as adjuvants in monoclonal antibody-based treatment (review) 44
Sentinel lymphadenectomy in cutaneous melanoma 44
PLATELET PROAGGREGATING ACTIVITY OF HUMAN COLORECTAL TUMOR-CELL LINES DOES NOT CORRELATE WITH THE DEGREE OF DIFFERENTIATION 44
IS THE CD54 PROTEIN (ICAM-1) INVOLVED IN PLATELET-TUMOR CELL-INTERACTION 44
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 44
CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation 44
Enhanced expression of LINE-1 encoded ORF2 protein in early stages of colon and prostate transformation 44
PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability 44
Machine learning approach to predict medication overuse in migraine patients 44
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 44
Is CEA serum measurement useful in monitoring breast cancer patients? 43
The insulin-glucose axis in breast cancer - relationship to clinical outcome 43
Serum tumor markers in gastrointestinal cancer patients: A prospective longitudinal study 43
Evaluation of the Clinical Impact of Serum Tumor Markers in Colorectal Cancer A Prospective Longitudinal Study 43
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 43
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients 43
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 43
Vascular endothelial growth factor levels in melanoma Relationship with coagulation and platelet activation markers 43
Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients 43
Plasma VEGF levels correlate with haemostatic activation in HCC patients 43
Fibrinolysis components in colorectal carcinoma 43
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea 43
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 43
Influence of interferon on the functional expression of natural killer target structures of murine lymphoma cells 43
Laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors: Report of a case 43
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 42
Circulating Levels of Pro-Inflammatory Cytokines in Isolated Limb Perfusion 42
A NOVEL NONSENSE MUTATION IN KRAS GENE 42
PRKCSH GAG trinucleotide repeat is a mutational target in gastric carcinomas with high-level microsatellite instability 42
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 42
CA-72-4 MEASUREMENT OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72) AS A SERUM MARKER IN THE MANAGEMENT OF GASTRIC-CARCINOMA 42
Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas 42
Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus 42
Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer 42
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab 42
Platelet activation and low-grade inflammation in hypertensives with or without microalbuminuria 42
CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers 42
Combined evaluation of CA 242 and CEA tumor markers in the management of colorectal cancer 42
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 42
CORRELATION BETWEEN THE PROPORTION OF PERIPHERAL BLOOD AND BONE MARROW LEUKEMIC CELLS IN HAIRY CELL LEUKEMIA AFTER TREATMENT 41
IS BREAST CANCER AN INTEGRAL BHD-RELATED TUMOR? 41
Serum Concentration of Soluble Adhesion Molecules and Cytokines in Patients with Colorectal Cancer 41
Early diagnosis of hepatocellular carcinoma in cirrhotic patients: Evaluation of new biologic markers 41
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 41
Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters 41
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 41
Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon 41
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 41
Novel High-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in cancer patients 40
CLINICAL-EVALUATION OF THE NEW TUMOR-MARKER TAG-72 40
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 40
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells 40
Totale 4.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.221
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020396 0 0 0 0 0 0 0 0 0 0 202 194
2020/20213.264 135 181 41 3 105 148 95 55 99 59 2.113 230
2021/20223.140 19 961 966 5 4 6 348 352 47 389 5 38
2022/20231.172 703 24 17 70 49 13 7 53 41 81 110 4
2023/2024710 6 2 21 152 36 48 15 35 0 63 5 327
2024/20252.404 158 642 144 110 162 499 197 145 325 20 2 0
Totale 11.875